VRPX
Virpax Pharmaceuticals, Inc.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Open
—
Prev close
0.00
Day high
0.02
Day low
0.02
Volume
51
Market cap
$248
P/E (TTM)
—
52W range
0.00 – 0.10
Trailing performance
Returnvs SPY
1W
+100.00%
+101.4%
1M
-50.00%
-53.7%
3M
-50.00%
-53.1%
6M
-98.20%
-109.3%
YTD
-98.20%
-110.5%
1Y
-98.18%
-118.2%
3Y
-100.00%
-174.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$248
Enterprise value$-1.51M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-12.07M
EPS (TTM)$-71.00
Free cash flow$-12.26M
Total cash$1.51M
Total debt$0
Book value / share$-1.53
Shares outstanding1.24M
Float1.05M
Short % of float1.81%
Dividend yield—
Beta (5Y)-16.33
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.00
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-2364.82%
Return on assets-135.01%
Debt / equity—
Current ratio0.63
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$12.07M | -$15.19M | -$21.65M | $0 |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Net income | -$12.07M | -$15.19M | -$21.65M | $0 |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2024 | -6.75 | 12.50 | +285.2% |
| Sep 2024 | -13.50 | -10.75 | +20.4% |
| Jun 2024 | -38.25 | -43.75 | -14.4% |
| Mar 2024 | — | -68.75 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10
Total on file
Moving averages & technicals
SMA 10
0.00
+53.85% from price
SMA 20
0.00
+73.91% from price
SMA 50
0.00
-96.00% from price
SMA 100
0.00
-94.89% from price
SMA 200
0.01
-97.79% from price
EMA 12
0.00
-40.78% from price
EMA 26
0.00
-87.37% from price
EMA 50
0.00
-93.34% from price
RSI (14)
20.8
Oversold
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
3.57% of price
Realised vol 30D
1041.3%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.01
Trend bias
Below 200
-97.79%
Risk profile
Beta vs SPY
13.38
More volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
1041.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.9%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
3.57% of price
Beta (reported)
-16.33
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.